Management of toxicities from antibody-drug conjugates

Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

Tumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesis.

Nature communications·2025

Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis.

JNCI cancer spectrum·2025

Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting.

Future oncology (London, England)·2025

Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.

Annals of surgical oncology·2025

Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.

Clinical advances in hematology & oncology : H&O·2026

Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.

Clinical advances in hematology & oncology : H&O·2026

Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer.

Clinical advances in hematology & oncology : H&O·2026

Safety and toxicity assessment of antisense oligonucleotides in brain-relevant human cellular models.

Molecular therapy. Nucleic acids·2026

Flavonoids and chalcones as selective α-glucosidase inhibitors: from enzymatic screening to validation using the human enzyme.

RSC medicinal chemistry·2026

Carbohydrate-Mediated Cellular Uptake of Boronic Acid Hybrids In Cellulo and Insulin-Deficient Zebrafish: Live Imaging and Application of Multiphoton FLIM.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Comparing the Cutaneous Impacts of a Topical Restructuring Serum versus. Injected Hyaluronic Acid (HA) and Their Combination as Potential Anti-Aging Strategies in Chinese Women: An In Vivo Study.

Dermatology and therapy·2026

Structural and mechanistic insights into the fungal glycosylphosphatidylinositol mannosyltransferase I complex.

Proceedings of the National Academy of Sciences of the United States of America·2026

Visible-light-induced glycosyl radicals from diverse precursors for C-glycosylation.

Organic & biomolecular chemistry·2026

Related Experiment Videos

Management of toxicities from antibody-drug conjugates

Related Concept Videos

Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

Tumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesis.

Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis.

Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting.

Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.

Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.

Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.

Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.

Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer.

Safety and toxicity assessment of antisense oligonucleotides in brain-relevant human cellular models.

Flavonoids and chalcones as selective α-glucosidase inhibitors: from enzymatic screening to validation using the human enzyme.

Carbohydrate-Mediated Cellular Uptake of Boronic Acid Hybrids In Cellulo and Insulin-Deficient Zebrafish: Live Imaging and Application of Multiphoton FLIM.

Comparing the Cutaneous Impacts of a Topical Restructuring Serum versus. Injected Hyaluronic Acid (HA) and Their Combination as Potential Anti-Aging Strategies in Chinese Women: An In Vivo Study.

Structural and mechanistic insights into the fungal glycosylphosphatidylinositol mannosyltransferase I complex.

Visible-light-induced glycosyl radicals from diverse precursors for C-glycosylation.

Related Experiment Videos

Management of toxicities from antibody-drug conjugates

Related Concept Videos

Related Articles